Mark Bush
Research Triangle Park Foundation(US)ViiV Healthcare (United Kingdom)(GB)
Publications by Year
Research Areas
Diabetes Treatment and Management, Veterinary Orthopedics and Neurology, Orthopedic Surgery and Rehabilitation, Hormonal and reproductive studies, Pharmacology and Obesity Treatment
Most-Cited Works
- → Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes(2009)235 cited
- → Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes(2008)197 cited
- → Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects(2009)177 cited
- → Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects(2012)104 cited
- → Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans(2011)104 cited
- → Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies(2014)63 cited